GeneDx Corp. (WGS)
NASDAQ: WGS
· Real-Time Price · USD
120.45
2.03 (1.71%)
At close: Oct 17, 2025, 3:19 PM
1.71% (1D)
| Bid | 120.21 |
| Market Cap | 3.46B |
| Revenue (ttm) | 362.32M |
| Net Income (ttm) | 1.41M |
| EPS (ttm) | 0.08 |
| PE Ratio (ttm) | 1505.69 |
| Forward PE | 47.14 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 120.46 |
| Volume | 173,128 |
| Avg. Volume (20D) | 686,154 |
| Open | 117.05 |
| Previous Close | 118.42 |
| Day's Range | 114.40 - 121.10 |
| 52-Week Range | 55.17 - 136.00 |
| Beta | 2.04 |
| Ex-Dividend Date | n/a |
Analyst Forecast
According to 0 analyst ratings, the average rating for WGS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsGeneDx Corp. is scheduled to release its earnings on
Oct 28, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+12.78%
GeneDx Holdings shares are trading higher after We...
Unlock content with
Pro Subscription
2 months ago
+8.09%
GeneDx shares are trading higher after the company raised FY25 sales guidance above estimates.
